Valuation: Jianmin Pharmaceutical Group Co.,Ltd.

Market Cap 4.09B 615M 551M 507M 459M 858M 58.41B 874M 6.04B 2.43B 30.72B 2.31B 2.26B 96.89B P/E 2024
17.5x
P/E 2025 14.2x
Enterprise Value 3.02B 453M 406M 373M 338M 632M 43.03B 644M 4.45B 1.79B 22.63B 1.7B 1.66B 71.37B EV / Sales 2024
1.56x
EV / Sales 2025 1.21x
Free-Float
66.4%
Yield 2024
2.16%
Yield 2025 2.68%
1 day+1.64%
1 week+0.87%
1 month-0.63%
3 months-5.35%
6 months-15.78%
Current year-20.49%
1 week 26
Extreme 26
26.99
1 month 25.6
Extreme 25.6
27.99
Current year 24.68
Extreme 24.68
35.87
1 year 24.68
Extreme 24.68
40.3
3 years 24.68
Extreme 24.68
72.3
5 years 24.68
Extreme 24.68
86.78
10 years 13.69
Extreme 13.69
86.78
Manager TitleAgeSince
President 50 08/09/2020
Director of Finance/CFO 54 01/01/2018
Compliance Officer 38 -
Director TitleAgeSince
Chairman 39 16/09/2019
Director/Board Member 55 02/08/2011
Director/Board Member 55 05/09/2013
Date Insider Type Main position Quantity % Market Cap. Importance
13/12/21 Sell

Chairman

5,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%+0.87%-32.29%-57.24% 615M
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +2.04%+5.30%+38.69%+70.38% 426.25B
Weighted average by Cap. +2.01%+6.60%+50.50%+100.41%

Financials

2024 2025
Net sales 3.5B 527M 472M 434M 393M 735M 50B 749M 5.17B 2.08B 26.3B 1.98B 1.93B 82.95B 3.37B 506M 453M 417M 378M 706M 48.07B 720M 4.97B 2B 25.29B 1.9B 1.86B 79.75B
Net income 362M 54.42M 48.73M 44.83M 40.62M 75.92M 5.17B 77.35M 535M 215M 2.72B 204M 200M 8.57B 360M 54.06M 48.42M 44.54M 40.36M 75.43M 5.13B 76.85M 531M 213M 2.7B 203M 199M 8.52B
Net Debt -942M -141M -127M -117M -106M -197M -13.43B -201M -1.39B -558M -7.07B -531M -520M -22.28B -1.08B -162M -145M -133M -121M -226M -15.38B -230M -1.59B -639M -8.09B -608M -595M -25.52B
Projected Income Statement - Annual - Jianmin Pharmaceutical Group Co.,Ltd.
Logo Jianmin Pharmaceutical Group Co.,Ltd.
Jianmin Pharmaceutical Group Co Ltd, formerly Wuhan Jianmin Pharmaceutical Groups Co Ltd, is a China-based company principally engaged in the research and development, manufacturing, wholesale and retail of pharmaceuticals. The Company operates its businesses through two segments. The Pharmaceutical Production and Sales segment is primarily engaged in the production of various types of Chinese patent medicines and sales to pharmaceutical distributors at all levels, including sales to the commercial division within the group that sells to non-hospitals. The Commercial segment is primarily engaged in the purchase of drugs from manufacturers and manufacturers' agents, and then distribution to lower-level distributors, sales to hospitals and retail sales in pharmacies. The Company mainly operates its businesses in the domestic market.
Employees
2,257
Date Price Change Volume
30/10/26 CN¥26.69 +1.64% 1,514,300
29/10/26 CN¥26.26 -0.34% 816,700
28/10/26 CN¥26.35 +0.57% 885,482
27/10/26 CN¥26.20 -1.91% 764,600
26/10/26 CN¥26.71 +0.94% 946,370

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Jianmin Pharmaceutical Group Co.,Ltd.
  1. Stock Market
  2. Stocks
  3. 600976 Stock